Since the protein product of the APOE gene, apolipoprotein E, modulates inflammatory and immune responses in an isoform-dependent manner [32], it may be hypothesized that the APOE4 genotype enhances the immune response as measured with CCL23 levels in both AD and PD and accelerates disease progression. The gene discussed is APOE; the disease is Parkinson disease.